Literature DB >> 20637675

Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines.

P H A Bours1, R Polak, A I M Hoepelman, E Delgado, A Jarquin, A J Matute.   

Abstract

BACKGROUND: The worldwide increasing resistance to antibiotics has complicated antimicrobial treatment of urinary tract infections (UTIs), especially in Latin America. This study aimed to report the present etiology and antimicrobial susceptibility of UTIs, and the effects of the national guidelines for UTIs introduced in 2003.
METHODS: Urine samples were collected from 304 patients with a clinical suspicion of UTI at the university hospital and primary health centers of León, Nicaragua. When bacterial growth was reported, antimicrobial susceptibility tests for nine frequently used antibiotics were performed.
RESULTS: Ninety-one (29.9%) patients had a positive urine culture. The most frequently isolated microorganisms were Escherichia coli (n=44), Serratia spp (n=11), and Escherichia fergusonii (n=10). High resistance rates were observed in E. coli to ampicillin (61.4%), cefalothin (45.5%), trimethoprim-sulfamethoxazole (38.6%), ciprofloxacin (31.8%), and ceftriaxone (20.5%). Amikacin and nitrofurantoin were the only drugs to which >90% of E. coli were susceptible. E. fergusonii and Serratia spp showed comparable high resistance patterns. Thirteen strains (29.5%) of E. coli were suspected to produce extended-spectrum beta-lactamase (ESBL).
CONCLUSIONS: Resistance rates in community-acquired UTIs in Nicaragua are increasing. The introduction of therapeutic guidelines with ceftriaxone recommended for upper UTIs and nitrofurantoin for lower UTIs, has led to increasing resistance against both antibiotics. The emergence of ESBL-producing E. coli is worrisome, along with the appearance of Serratia spp in the population.
Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637675     DOI: 10.1016/j.ijid.2010.02.2264

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  15 in total

1.  Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Authors:  Patrick D Vigil; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian.

Authors:  Monali Priyadarsini Mishra; Nagen Kumar Debata; Rabindra Nath Padhy
Journal:  Asian Pac J Trop Biomed       Date:  2013-04

Review 3.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Enhanced Antibiotic Tolerance of an In Vitro Multispecies Uropathogen Biofilm Model, Useful for Studies of Catheter-Associated Urinary Tract Infections.

Authors:  Jiapeng Hou; Lutian Wang; Martin Alm; Peter Thomsen; Tor Monsen; Madeleine Ramstedt; Mette Burmølle
Journal:  Microorganisms       Date:  2022-06-13

5.  An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study.

Authors:  Menyfah Q Alanazi; Fulwah Y Alqahtani; Fadilah S Aleanizy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-02-09       Impact factor: 3.944

6.  Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns.

Authors:  Jane-Francis Tatah Kihla Akoachere; Suylika Yvonne; Njom Henry Akum; Esemu Nkie Seraphine
Journal:  BMC Res Notes       Date:  2012-05-07

Review 7.  Resistant gram-negative infections in the outpatient setting in Latin America.

Authors:  M J C Salles; J Zurita; C Mejía; M V Villegas
Journal:  Epidemiol Infect       Date:  2013-08-07       Impact factor: 2.451

8.  Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department.

Authors:  Thana Khawcharoenporn; Shawn Vasoo; Kamaljit Singh
Journal:  Emerg Med Int       Date:  2013-10-31       Impact factor: 1.112

9.  In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study.

Authors:  Douglas J Biedenbach; Robert E Badal; Ming-Yi Huang; Mary Motyl; Puneet K Singhal; Roman S Kozlov; Arthur Dessi Roman; Stephen Marcella
Journal:  Infect Dis Ther       Date:  2016-06-10

10.  Virulence and antimicrobial resistance of common urinary bacteria from asymptomatic students of Niger Delta University, Amassoma, Bayelsa State, Nigeria.

Authors:  Adebola Onanuga; Tamaradobra Laurretta Selekere
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.